- Home
- CIX vs ZBIO Comparison
CIX vs ZBIO Comparison
Compare CIX & ZBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CIX
- ZBIO
- Stock Information
- Founded
- CIX 1993
- ZBIO 2019
- Country
- CIX United States
- ZBIO United States
- Employees
- CIX N/A
- ZBIO N/A
- Industry
- CIX Industrial Machinery/Components
- ZBIO
- Sector
- CIX Consumer Discretionary
- ZBIO
- Exchange
- CIX Nasdaq
- ZBIO NYSE
- Market Cap
- CIX 296.3M
- ZBIO 268.7M
- IPO Year
- CIX 1998
- ZBIO 2024
- Fundamental
- Price
- CIX $21.61
- ZBIO $8.25
- Analyst Decision
- CIX
- ZBIO Strong Buy
- Analyst Count
- CIX 0
- ZBIO 6
- Target Price
- CIX N/A
- ZBIO $31.83
- AVG Volume (30 Days)
- CIX 9.1K
- ZBIO 136.9K
- Earning Date
- CIX 03-05-2025
- ZBIO 03-25-2025
- Dividend Yield
- CIX 5.36%
- ZBIO N/A
- EPS Growth
- CIX N/A
- ZBIO N/A
- EPS
- CIX 1.35
- ZBIO N/A
- Revenue
- CIX $145,941,000.00
- ZBIO $5,000,000.00
- Revenue This Year
- CIX N/A
- ZBIO N/A
- Revenue Next Year
- CIX N/A
- ZBIO N/A
- P/E Ratio
- CIX $16.61
- ZBIO N/A
- Revenue Growth
- CIX N/A
- ZBIO N/A
- 52 Week Low
- CIX $20.60
- ZBIO $5.83
- 52 Week High
- CIX $39.91
- ZBIO $26.25
- Technical
- Relative Strength Index (RSI)
- CIX 38.91
- ZBIO N/A
- Support Level
- CIX $21.59
- ZBIO N/A
- Resistance Level
- CIX $23.00
- ZBIO N/A
- Average True Range (ATR)
- CIX 1.15
- ZBIO 0.00
- MACD
- CIX -0.10
- ZBIO 0.00
- Stochastic Oscillator
- CIX 6.92
- ZBIO 0.00
About CIX CompX International Inc.
Compx International Inc is a manufacturer of security products. Its security products are used in recreational transportation, postal, office & institutional furniture, cabinetry, tool storage, healthcare, and a variety of other industries. Also, it is engaged in the manufacturing of stainless steel exhaust systems, gauges, throttle controls, and trim tabs for the recreational marine industry. The company's operating segment includes Security Products and Marine Components. The company generates maximum revenue from the Security Products segment, which manufactures mechanical and electrical cabinet locks and other locking mechanisms. Its geographical segments are the United States, Canada, Mexico, and others, of which the United States accounts for the vast majority of revenue.
About ZBIO ZENAS BIOPHARMA INC
Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them.